Robert K. Evans
26Patents
8h-index
50Co-inventors
78Inventor score
Filing activity: May 31, 1977 → Jan 14, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6228779A | Ultra thin oxynitride and nitride/oxide stacked gate dielectrics fabricated by high pressure technology | Electricity | 40 | Expired |
| US4130126A | Ink maintenance sensor | Emerging Cross-Sectional Technologies | 25 | Expired |
| US10059771B2 | Methods for treating nasal polyposis by administering an IL-4R antagonist | Chemistry; Metallurgy | 18 | Active |
| US10066017B2 | Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist | Chemistry; Metallurgy | 17 | Active |
| US8420102B2 | Compositions that include hemagglutinin | Emerging Cross-Sectional Technologies | 13 | Active |
| US7456009B2 | Adenovirus formulations | Chemistry; Metallurgy | 11 | Expired |
| US6387695B1 | DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof | Human Necessities | 9 | Expired |
| US9056901B2 | Methods of making hemagglutinin proteins | Emerging Cross-Sectional Technologies | 9 | Active |
| US10532093B2 | Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof | Chemistry; Metallurgy | 7 | Active |
| US7927870B2 | DNA vaccine formulations | Chemistry; Metallurgy | 6 | Active |
| US7351415B2 | Adenovirus formulations | Chemistry; Metallurgy | 5 | Expired |
| US8945579B2 | Methods of treatment with compositions that include hemagglutinin | Emerging Cross-Sectional Technologies | 5 | Active |
| US9782470B2 | Method of obtaining thermostable dried vaccine formulations | Emerging Cross-Sectional Technologies | 5 | Active |
| US4672111A | 5-azido-deoxyuridine compounds and method of synthesis of the same | Chemistry; Metallurgy | 3 | Expired |
| US10350289B2 | Methods of immunization with varicella zoster virus antigen | Chemistry; Metallurgy | 3 | Active |
| US10314904B2 | Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist | Emerging Cross-Sectional Technologies | 2 | Active |
| US10617650B2 | Process for preparing formulations for gastrointestinal-targeted therapies | Human Necessities | 2 | Active |
| US11214621B2 | Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist | Chemistry; Metallurgy | 2 | Active |
| US5096810A | Monoclonal antibodies for diagnosis of hairy cell leukemia | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9200042B2 | Flagellin fusion proteins | Emerging Cross-Sectional Technologies | 1 | Active |
| US10183968B2 | Methods of preparing lyophilized spherical-shaped pellets of biological materials | Chemistry; Metallurgy | 0 | Active |
| US10556000B2 | Thermostable spray dried rotavirus vaccine formulation and process thereof | Chemistry; Metallurgy | 0 | Active |
| US10369213B2 | Thermostable respiratory synctial virus (RSV) vaccine compositions | Chemistry; Metallurgy | 0 | Active |
| US12371506B2 | Subcutaneous administration of anti-CD38 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10874732B2 | Thermally stable rotavirus vaccine formulations and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.